A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors
Clinical trial NCT04481009 · COMPLETED
Trial details
- NCT number
- NCT04481009
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2022-05-16
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.